Clinical trial

Basal Bolus Versus Basal Insulin in Type 2 Diabetes Mellitus (T2DM)

NCT00979628

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2010-01-01

PhasePHASE4

Study timeline

Study start (unknown)2010-01-01Date precision: month

Registry last updated2018-10-10

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 2 Diabetesunresolved

Hyperglycemiaunresolved

Interventions

sliding scale regular insulin (SSRI)DRUG

Basal BolusDRUG

Sponsors & collaborators

Guillermo Umpierrez, MDlead sponsor

Sanoficollaborator

Medical University of South Carolinacollaborator

Texas A&M Universitycollaborator

Mapped research locations

AtlantaGeorgia, United States2 CharlestonSouth Carolina, United States1 DecaturGeorgia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00979628 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.